| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/21/2003 | EP1311296A2 Solution of an oxazolidinone antibiotic drug |
| 05/21/2003 | EP1311295A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 05/21/2003 | EP0971709B1 Novel compounds useful as neuro-protective agents |
| 05/21/2003 | EP0964863B1 Oxazolidines as 5-ht2a-antagonists |
| 05/21/2003 | CN1419549A Method for producing asymmetrical 4,6-bis (aryloxy) pyrimidine derivatives |
| 05/21/2003 | CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 05/21/2003 | CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403 |
| 05/21/2003 | CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound |
| 05/21/2003 | CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 05/21/2003 | CN1109026C Sidechain-beering taxanes like compounds |
| 05/21/2003 | CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof |
| 05/20/2003 | US6566536 Thienylsulphonylamino(thio)carbonyl compounds |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566468 Provide polymeric resin products having low polydispersity; polymers produced contain a glycidyl or alkylcarbonyl group attached to the starting molecule of the radical chain reaction. |
| 05/20/2003 | US6566385 And the prenylation of the oncogene protein Ras; peptidomimetic macrocyclic compounds |
| 05/20/2003 | US6566383 Sulfonyltriazol derivatives and their use for combating micro-organisms |
| 05/20/2003 | US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease |
| 05/20/2003 | US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/20/2003 | US6566376 Diphenyl-piperidine derivative |
| 05/20/2003 | US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer |
| 05/20/2003 | US6566364 Linear or cyclic ureas |
| 05/20/2003 | US6566358 Cyclocarbamate derivatives as progesterone receptor modulators |
| 05/20/2003 | US6566340 Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use |
| 05/20/2003 | CA2234239C Indole carbamates as leukotriene antagonists |
| 05/20/2003 | CA2137694C Acaricide |
| 05/15/2003 | WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________ |
| 05/15/2003 | WO2003040142A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase |
| 05/15/2003 | WO2003040141A1 Oxazolyl-phenyl-2,4-diamino-pyrimidine compounds and methods for treating hyperproliferative disorders |
| 05/15/2003 | WO2003040140A1 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 05/15/2003 | WO2003040129A1 Halogenated nitrobutadienes for controlling animal pests |
| 05/15/2003 | WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity |
| 05/15/2003 | WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 05/15/2003 | WO2003040114A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 05/15/2003 | WO2003040112A1 Substituted diphenyl heterocycles useful for treating hcv infection |
| 05/15/2003 | WO2003040110A1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 05/15/2003 | WO2003040109A2 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | WO2003040108A1 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 05/15/2003 | WO2003040106A1 Preparation and use of substituted imidazoles |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | WO2003039460A2 Mitotic kinesin inhibitors |
| 05/15/2003 | WO2003039440A2 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage |
| 05/15/2003 | WO2003000692A3 Oxytocin agonists |
| 05/15/2003 | US20030092917 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as portein kinase inhibitors |
| 05/15/2003 | US20030092916 Process for the preparation of thiazolidinedione derivatives |
| 05/15/2003 | US20030092751 3-glyoxlylamideindoles for treating cancer |
| 05/15/2003 | US20030092749 Kinase inhibitors; antiinflammatory agents; osteoporosis; anticancer agents |
| 05/15/2003 | US20030092747 Secretase inhibitor |
| 05/15/2003 | US20030092740 Anticoagulants |
| 05/15/2003 | US20030092736 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 05/15/2003 | US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases |
| 05/15/2003 | US20030092723 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives |
| 05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
| 05/15/2003 | US20030092714 Heterocyclic inhibitors of ERK2 and uses thereof |
| 05/15/2003 | US20030092711 Contraceptives; hormone replacement therapy |
| 05/15/2003 | US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases |
| 05/15/2003 | US20030092697 Antidiabetic, antilipemic agents; cardiovascular disorders; anticancer agents |
| 05/15/2003 | US20030092694 Central nervous system disorders; side effect reduction |
| 05/15/2003 | US20030092680 Novel pesticides |
| 05/15/2003 | US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 05/15/2003 | US20030092677 Glutamate receptor antagonists |
| 05/15/2003 | CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 05/15/2003 | CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 05/15/2003 | CA2465680A1 Piperazine derivatives having sst1 antagonistic activity |
| 05/15/2003 | CA2465491A1 Mitotic kinesin inhibitors |
| 05/15/2003 | CA2465189A1 Substituted diphenyl heterocycles useful for treating hcv infection |
| 05/15/2003 | CA2465100A1 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | CA2465068A1 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 05/14/2003 | EP1310495A2 Glycidyl amines and their use in the preparation of HIV protease inhibitors |
| 05/14/2003 | EP1310494A1 PPAR (delta) ACTIVATORS |
| 05/14/2003 | EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 05/14/2003 | EP1309593A2 Substituted pyrazoles |
| 05/14/2003 | EP1309592A2 Substituted pyrazoles |
| 05/14/2003 | EP1309588A1 Heterocyclylalkyl azole derivatives and use thereof as pesticidal agents |
| 05/14/2003 | EP1309573A1 Urethane derivatives |
| 05/14/2003 | EP1309571A1 Non-steroidal inflammation inhibitors |
| 05/14/2003 | EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 05/14/2003 | EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 05/14/2003 | EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 05/14/2003 | EP1309551A1 Indoline derivatives as 5ht2c antagonists |
| 05/14/2003 | EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 05/14/2003 | CN1418212A Method for producing 7-(phrazole-3-yl) benzoxazoles |
| 05/14/2003 | CN1418193A heterocyclic side chain containing metalloprotease inbibitors |
| 05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 05/14/2003 | CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed |
| 05/13/2003 | US6564152 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists |
| 05/13/2003 | US6563003 Process to produce amino alcohol salts |
| 05/13/2003 | US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS |
| 05/13/2003 | US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst |
| 05/13/2003 | US6562964 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders |
| 05/13/2003 | US6562944 Generation of preferential halogen compound; obtain carboxylic acid mixture, incubabte with halogenated compound, recover by-product |
| 05/13/2003 | US6562857 Cyanopyrroles |
| 05/13/2003 | US6562854 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders |
| 05/13/2003 | US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion |
| 05/13/2003 | US6562849 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc. |
| 05/13/2003 | US6562844 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| 05/13/2003 | US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders |